Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building flexible, scalable solutions for life sciences organizations to Trinity.
As CTO, Mr. Rangachari will infuse technology into every aspect of Trinity’s offerings and workflow, accelerating business processes with technology assets. He will lead a global team of technologists and life sciences domain experts as they focus on the new opportunities in Artificial Intelligence (AI), drive innovation in spaces that aren’t traditionally tech-enabled and ensure adoption of best practices in security and compliance.
“Generative AI and, more broadly, AIML in all its forms will be transformative for life sciences in the next few years. As we tackle these technological disruptions on behalf of our clients, having a seasoned technology leader in the new CTO role is vital,” explained Leslie Orne, President & CEO of Trinity Life Sciences. “I am delighted Rajeev is on the team and bringing his high-energy, outcomes-focused leadership style and unique skillset to bear on these crucial initiatives.”
“From a global life sciences technology perspective, the power of Generative AI provides an opportunity to bring people without technical backgrounds into the leading edge of data science,” added Rajeev Rangachari, CTO of Trinity Life Sciences. “I am honored to lead Trinity’s technology strategy at such an exciting moment and look forward to bolstering an already innovative culture by enhancing and developing world-class tools and technology that support life sciences commercialization.”
Prior to accepting the CTO role, Mr. Rangachari most recently served as D Cube Analytics’ Chief Technology Officer. D Cube Analytics was acquired by Trinity Life Sciences in July 2022.
SOURCE: BusinessWire
